Prodesse Licenses Multiplexing, Molecular Detection Patents from Abbott | GenomeWeb

NEW YORK (GenomeWeb News) – Prodesse has licensed two patents from Abbott that cover multiplexing and molecular detection technologies, the Wisconsin-based company said yesterday.

Under the agreement, Prodesse acquired non-exclusive sub-licenses for US Patent No. 5,582,989, and US Patent No. 5,851,767.

The '989 "Caskey" patent, assigned to Baylor College of Medicine, covers molecular multiplexing and the '767 "Stanbridge" patent, assigned to the University of California, covers molecular detection of prokaryotic organisms, mostly bacteria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.